Global Health IPO - A Largest Multi Speciality Hospital Chain In North, East India: Geojit
As of June 30, 2022, Medanta provides healthcare services in over 30 medical specialties and engages over 1,300 doctors.
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Geojit Research's IPO Report
Global Health Ltd. (Medanta), incorporated on August 13, 2004, at New Delhi, is one of the largest private multi-speciality hospital chains operating in the North and East regions of India.
As per the CRISIL report, its key specialties are cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedic, liver transplant, and kidney and urology.
Medanta has a network of five hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital under construction (Noida).
As of June 30, 2022, Medanta provides healthcare services in over 30 medical specialties and engages over 1,300 doctors, spanning an area of 4.7 million square feet with 2,467 installed beds.
Revenue from operations grew at ~50% YoY in FY22 and ~27% YoY in Q1 FY23, led by an rise in patient volumes, bed occupancy levels (~61% in FY22) and increase in average revenue per occupied bed (~up by 14% YoY in FY22).
Click on the attachment to read the full IPO report:
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.